Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
US Market
Holding PCSA?
Track your performance easily

Processa Pharmaceuticals (PCSA) Financial Statements

133 Followers

Processa Pharmaceuticals Financial Overview

Processa Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.017; its P/E ratio is -0.22; Processa Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.38M$ -3.01M$ 2.89M$ -2.40M$ -2.17M
EBITDA$ -3.38M$ -3.01M$ 2.89M$ -2.40M$ -2.17M
Net Income Common Stockholders$ -3.38M$ -3.01M$ -2.70M$ -2.38M$ -2.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.90M$ 5.60M$ 8.90M$ 4.70M$ 6.90M
Total Assets$ 4.94M$ 7.60M$ 9.94M$ 5.79M$ 8.08M
Total Debt$ 0.00$ 0.00$ 0.00$ 150.55K$ 171.52K
Net Debt$ -2.90M$ -5.60M$ -8.90M$ -4.55M$ -6.73M
Total Liabilities$ 1.22M$ 1.58M$ 1.06M$ 797.48K$ 914.85K
Stockholders Equity$ 3.72M$ 6.02M$ 8.88M$ 4.99M$ 7.17M
Cash Flow-
Free Cash Flow$ -3.60M$ -3.40M$ -2.00M$ -2.20M$ -1.76M
Operating Cash Flow$ -3.60M$ -3.40M$ -2.00M$ -2.20M$ -1.76M
Investing Cash Flow$ -3.24K---$ -2.78K
Financing Cash Flow$ 926.20K$ -3.41K$ 6.26M$ -30.61K$ -52.75K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History

Processa Pharmaceuticals Debt to Assets

Processa Pharmaceuticals Cash Flow

Processa Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis